Your browser doesn't support javascript.
loading
Anticancer activity of a novel small molecule tubulin inhibitor STK899704.
Sakchaisri, Krisada; Kim, Sun-Ok; Hwang, Joonsung; Soung, Nak Kyun; Lee, Kyung Ho; Choi, Tae Woong; Lee, Yongjun; Park, Chan-Mi; Thimmegowda, Naraganahalli R; Lee, Phil Young; Shwetha, Bettaswamigowda; Srinivasrao, Ganipisetti; Pham, Thi Thu Huong; Jang, Jae-Hyuk; Yum, Hye-Won; Surh, Young-Joon; Lee, Kyung S; Park, Hwangseo; Kim, Seung Jun; Kwon, Yong Tae; Ahn, Jong Seog; Kim, Bo Yeon.
Afiliação
  • Sakchaisri K; Anticancer Agents Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Cheongwon, Korea.
  • Kim SO; Department of Pharmacology, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
  • Hwang J; Anticancer Agents Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Cheongwon, Korea.
  • Soung NK; Anticancer Agents Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Cheongwon, Korea.
  • Lee KH; Anticancer Agents Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Cheongwon, Korea.
  • Choi TW; Anticancer Agents Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Cheongwon, Korea.
  • Lee Y; Anticancer Agents Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Cheongwon, Korea.
  • Park CM; Anticancer Agents Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Cheongwon, Korea.
  • Thimmegowda NR; Anticancer Agents Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Cheongwon, Korea.
  • Lee PY; Anticancer Agents Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Cheongwon, Korea.
  • Shwetha B; Anticancer Agents Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Cheongwon, Korea.
  • Srinivasrao G; Anticancer Agents Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Cheongwon, Korea.
  • Pham TT; Anticancer Agents Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Cheongwon, Korea.
  • Jang JH; Anticancer Agents Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Cheongwon, Korea.
  • Yum HW; The Key Laboratory of Enzyme & Protein Technology (KLEPT), VNU University of Science, Vietnam National University, Hanoi, Vietnam.
  • Surh YJ; Anticancer Agents Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Cheongwon, Korea.
  • Lee KS; College of Pharmacy, Seoul National University, Seoul, Korea.
  • Park H; College of Pharmacy, Seoul National University, Seoul, Korea.
  • Kim SJ; Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Kwon YT; Department of Bioscience and Biotechnology, Sejong University, Seoul, Korea.
  • Ahn JS; Disease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea.
  • Kim BY; Department of Biomedical Sciences and Protein Metabolism Medical Research Center, College of Medicine, Seoul National University, Seoul, Korea.
PLoS One ; 12(3): e0173311, 2017.
Article em En | MEDLINE | ID: mdl-28296906
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Benzofuranos / Moduladores de Tubulina / Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Benzofuranos / Moduladores de Tubulina / Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article